human bc cell lines sw780 Search Results


96
ATCC human sw780 tcc derived cells
Human Sw780 Tcc Derived Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human sw780 tcc derived cells/product/ATCC
Average 96 stars, based on 1 article reviews
human sw780 tcc derived cells - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

97
ATCC human bca cell lines
Human Bca Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bca cell lines/product/ATCC
Average 97 stars, based on 1 article reviews
human bca cell lines - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

99
ATCC carcinoma atcc crl 1469 tm sw780 bladder carcinoma atcc crl 2169 tm fadu head
Carcinoma Atcc Crl 1469 Tm Sw780 Bladder Carcinoma Atcc Crl 2169 Tm Fadu Head, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carcinoma atcc crl 1469 tm sw780 bladder carcinoma atcc crl 2169 tm fadu head/product/ATCC
Average 99 stars, based on 1 article reviews
carcinoma atcc crl 1469 tm sw780 bladder carcinoma atcc crl 2169 tm fadu head - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637
Human Bc Cells Lines (Umuc3, Tccsup, T24, Rt4, Sw780, 5637, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

95
Taconic Biosciences human sw780 bladder cancer cells
Human Sw780 Bladder Cancer Cells, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human sw780 bladder cancer cells/product/Taconic Biosciences
Average 95 stars, based on 1 article reviews
human sw780 bladder cancer cells - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

99
ATCC human bladder cancer lines
Human Bladder Cancer Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder cancer lines/product/ATCC
Average 99 stars, based on 1 article reviews
human bladder cancer lines - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

97
ATCC cell lines
Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell lines/product/ATCC
Average 97 stars, based on 1 article reviews
cell lines - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

95
ATCC human bladder cancer cells
Human Bladder Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder cancer cells/product/ATCC
Average 95 stars, based on 1 article reviews
human bladder cancer cells - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

96
ATCC human bladder cancer cell lines
Human Bladder Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder cancer cell lines/product/ATCC
Average 96 stars, based on 1 article reviews
human bladder cancer cell lines - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
Procell Inc human bladder carcinoma sw780 (grade i) cells
MAP1A gene expression and prognosis validation. (A) Validation of MAP1A expression in bladder cancer tissue samples and normal tissue samples using the GEPIA database and the GETx database. (B) MAP1A expression in bladder cancer cells <t>SW780</t> and 5637, as well as normal bladder epithelial cells SV-HUC-1. (C) MAP1A in the GEPIA database for overall survival analysis of bladder cancer. (D) MAP1A correlation with disease-free survival in bladder cancer (GEPIA database). (E) MAP1A expression in bladder cancer tissues (immunohistochemistry, HPA database). (F) MAP1A expression in pan-cancer. (* indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001). BRCA, Breast invasive carcinoma; CHOL, Cholangiocarcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and neck cancer; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD: Prostate adenocarcinoma; READ, Rectum adenocarcinoma; STAD, Stomach adenocarcinoma; THCA, Thyroid carcinoma; UCEC, Uterine corpus endometrial carcinoma. (G) The expression of MAP1A in different stage of bladder cancer.
Human Bladder Carcinoma Sw780 (Grade I) Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder carcinoma sw780 (grade i) cells/product/Procell Inc
Average 90 stars, based on 1 article reviews
human bladder carcinoma sw780 (grade i) cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
ATCC blca cell lines
MAP1A gene expression and prognosis validation. (A) Validation of MAP1A expression in bladder cancer tissue samples and normal tissue samples using the GEPIA database and the GETx database. (B) MAP1A expression in bladder cancer cells <t>SW780</t> and 5637, as well as normal bladder epithelial cells SV-HUC-1. (C) MAP1A in the GEPIA database for overall survival analysis of bladder cancer. (D) MAP1A correlation with disease-free survival in bladder cancer (GEPIA database). (E) MAP1A expression in bladder cancer tissues (immunohistochemistry, HPA database). (F) MAP1A expression in pan-cancer. (* indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001). BRCA, Breast invasive carcinoma; CHOL, Cholangiocarcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and neck cancer; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD: Prostate adenocarcinoma; READ, Rectum adenocarcinoma; STAD, Stomach adenocarcinoma; THCA, Thyroid carcinoma; UCEC, Uterine corpus endometrial carcinoma. (G) The expression of MAP1A in different stage of bladder cancer.
Blca Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blca cell lines/product/ATCC
Average 94 stars, based on 1 article reviews
blca cell lines - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


MAP1A gene expression and prognosis validation. (A) Validation of MAP1A expression in bladder cancer tissue samples and normal tissue samples using the GEPIA database and the GETx database. (B) MAP1A expression in bladder cancer cells SW780 and 5637, as well as normal bladder epithelial cells SV-HUC-1. (C) MAP1A in the GEPIA database for overall survival analysis of bladder cancer. (D) MAP1A correlation with disease-free survival in bladder cancer (GEPIA database). (E) MAP1A expression in bladder cancer tissues (immunohistochemistry, HPA database). (F) MAP1A expression in pan-cancer. (* indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001). BRCA, Breast invasive carcinoma; CHOL, Cholangiocarcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and neck cancer; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD: Prostate adenocarcinoma; READ, Rectum adenocarcinoma; STAD, Stomach adenocarcinoma; THCA, Thyroid carcinoma; UCEC, Uterine corpus endometrial carcinoma. (G) The expression of MAP1A in different stage of bladder cancer.

Journal: Frontiers in Oncology

Article Title: Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction

doi: 10.3389/fonc.2022.1016542

Figure Lengend Snippet: MAP1A gene expression and prognosis validation. (A) Validation of MAP1A expression in bladder cancer tissue samples and normal tissue samples using the GEPIA database and the GETx database. (B) MAP1A expression in bladder cancer cells SW780 and 5637, as well as normal bladder epithelial cells SV-HUC-1. (C) MAP1A in the GEPIA database for overall survival analysis of bladder cancer. (D) MAP1A correlation with disease-free survival in bladder cancer (GEPIA database). (E) MAP1A expression in bladder cancer tissues (immunohistochemistry, HPA database). (F) MAP1A expression in pan-cancer. (* indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001). BRCA, Breast invasive carcinoma; CHOL, Cholangiocarcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and neck cancer; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD: Prostate adenocarcinoma; READ, Rectum adenocarcinoma; STAD, Stomach adenocarcinoma; THCA, Thyroid carcinoma; UCEC, Uterine corpus endometrial carcinoma. (G) The expression of MAP1A in different stage of bladder cancer.

Article Snippet: Human bladder carcinoma SW780 (Grade I) and 5637 (Grade II) cells, as well as human bladder epithelial cell SV-HUC-1, were obtained from Procell Life Science & Technology Co., Ltd. (Wuhan, China).

Techniques: Gene Expression, Biomarker Discovery, Expressing, Immunohistochemistry